Impact of Genetic Polymorphisms in NF- ĸB2 and TRAF3 Genes on Response to Bortezomib-Based Therapy in Multiple Myeloma Patients
CONCLUSION: The study findings underscore a significant association between genetic polymorphisms and treatment response outcomes, suggesting their utility in prognostic determinations and clinical outcomes prediction in multiple myeloma patients.PMID:38546066 | DOI:10.31557/APJCP.2024.25.3.829
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Authors: Nidhi Sood Abdoul Hamide Biswajit Dubashi Yadav Nisha Jayanthi Mathaiyan A K Munirajan Prasanth Ganesn Smita Kayal Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Genetics | Hematology | Myeloma | Orthopaedics | Renal Failure | Study | Velcade